Geraldine Runyon, | |
15 Periwinkle Ln, Long Beach, MS 39560-6364 | |
(228) 263-4447 | |
Not Available |
Full Name | Geraldine Runyon |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 15 Periwinkle Ln, Long Beach, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205187416 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Geraldine Runyon, 15 Periwinkle Ln, Long Beach, MS 39560-6364 Ph: (228) 263-4447 | Geraldine Runyon, 15 Periwinkle Ln, Long Beach, MS 39560-6364 Ph: (228) 263-4447 |
News Archive
Helix BioPharma Corp. today announced financial results for the first quarter ended October 31, 2009.
Daytime sleepiness is very common in the elderly with prevalence rates of up to 50 percent. Caused by sleep-disordered breathing, a disruption of normal breathing during sleep, these cause recurrent awakenings and subsequent excessive daytime sleepiness.
An international research group led by Arizona State University professor Qiang "Shawn" Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.
Use of low energy sweeteners (LES) in place of sugar, in children and adults, leads to reduced calorie intake and body weight - and possibly also when comparing LES beverages to water - according to a review led by researchers at the University of Bristol published in the International Journal of Obesity today.
"Glucocorticoids are a key component of combination therapy regimens in multiple myeloma and other hematological cancers. However, glucocorticoid use comes with substantial dose limiting toxicities. The ability to enhance glucocorticoid dependent effects while sparing associated toxicities may have important implications for the treatment of multiple myeloma and other B-cell malignancies"
› Verified 9 days ago